文献速递系统性红斑狼疮

单细胞转录组孟德尔随机化与共定位揭示系统性红斑狼疮细胞特异性机制

Single-cell transcriptome-wide Mendelian randomization and colocalization reveal cell-specific mechanisms in systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究整合14种人类免疫细胞类型的单细胞表达数量性状位点数据与孟德尔随机化及贝叶斯共定位分析,识别与SLE因果相关的eGene。MR分析鉴定出62个对SLE有显著因果效应的eGene,共定位分析优先筛选出8个共享遗传调控证据强的eGene(PP.H4>80%),包括BLK、RNF145、FAM167A和VRK3。PheWAS显示多数候选eGene与非免疫性状关联少,BLK表达升高具保护性但为fostamatinib和zanubrutinib靶点,提示抑制BLK在SLE中可能存在风险。

要点

  • MR分析鉴定62个对SLE有显著因果效应的eGene,跨多种免疫细胞类型。
  • 共定位分析优先筛选8个与SLE共享遗传调控证据强的eGene(PP.H4>80%)。
  • BLK表达升高具保护性,但为fostamatinib和zanubrutinib靶点,抑制可能存在风险。

核心结论

  • 整合sc-eQTL、MR和共定位分析可识别SLE中免疫细胞特异性因果eGene,为精准药物开发提供有前景的低风险治疗靶点。

研究设计与样本

  • 研究整合14种人类免疫细胞类型的单细胞表达数量性状位点(sc-eQTL)数据,采用孟德尔随机化(MR)和贝叶斯共定位分析识别与SLE因果相关的eGene。
  • 应用全表型组关联研究(PheWAS)评估候选eGene的潜在脱靶效应,并使用DrugBank识别靶向这些eGene的现有药物。

主要发现

  • MR分析鉴定出62个对SLE有显著因果效应的eGene,分布于多种免疫细胞类型。
  • 共定位分析优先筛选出8个与SLE共享遗传调控证据强的eGene(PP.H4>80%),包括BLK、RNF145、FAM167A和VRK3。
  • PheWAS分析显示多数候选eGene与非免疫性状的显著关联少,提示不良效应风险低。
  • BLK是fostamatinib和zanubrutinib的已知靶点,但其表达升高具保护性,提示抑制BLK在SLE中可能存在风险。

关键数值与推荐

  • 共定位分析中PP.H4>80%用于优先筛选eGene。

临床怎么用

  • 研究结果提供SLE的免疫细胞特异性因果eGene及有前景的低风险治疗靶点,支持精准药物开发。
  • BLK表达升高具保护性且为fostamatinib和zanubrutinib靶点,提示抑制BLK在SLE中可能存在风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: SLE is a multifactorial autoimmune disease with complex genetic architecture and immune cell involvement. While genome-wide association studies (GWAS) have identified numerous risk loci, most are non-coding, making it challenging to pinpoint causal eGenes [genes with expression quantitative trait loci (eQTLs)] and therapeutic targets. METHODS: We integrated single-cell expression quantitative trait loci (sc-eQTL) data from 14 human immune cell types with Mendelian randomization (MR) and Bayesian colocalization analyses to identify eGenes causally associated with SLE. We applied phenome-wide association studies (PheWAS) to assess potential off-target effects of candidate eGenes and used DrugBank to identify existing drugs targeting these eGenes. RESULTS: MR analysis identified 62 eGenes with significant causal effects on SLE across diverse immune cell types. Colocalization analysis prioritized eight eGenes with strong evidence of shared genetic regulation with SLE (PP.H4 >80%), including BLK (B lymphoid tyrosine kinase), RNF145 (Ring Finger Protein 145), FAM167A (Family with Sequence Similarity 167 Member A) and VRK3 (Vaccinia-Related Kinase 3). PheWAS analyses revealed few significant associations with non-immune traits for most candidate eGenes, suggesting low risk of adverse effects. Notably, BLK is a known target of fostamatinib and zanubrutinib, although its increased expression was protective, highlighting potential risks of inhibition in SLE. CONCLUSION: This study demonstrates the utility of integrating sc-eQTL, MR and colocalization analyses to identify immune cell-specific causal eGenes in SLE. The findings offer new insights into disease mechanisms and highlight promising, low-risk therapeutic targets for precision drug development.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Hong Y, Ye J, Hua C, et al. Single-cell transcriptome-wide Mendelian randomization and colocalization reveal cell-specific mechanisms in systemic lupus erythematosus. Rheumatology (Oxford). 2026. PMID: 41233983. doi:10.1093/rheumatology/keaf606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。